Hemifacial Spasm:Clinical Findings and Treatment
Muscle & Nerve 21:1740-1747, Wang,A & Jankovic,J, 1998
Treatment of Hemifacial Spasm with Botulinum Toxin
Muscle & Nerve 15:1045-1049992., Yoshimura,D.M.,et al, 1992
Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Botulism in 4 Adults Following Cosmetic Injections With an Unlicensed, Highly Concentrated Botulinum Preparation
JAMA 296:2476-2479,2512, Chertow,D.S.,et al, 2006
Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003
Botulinum Toxin as a Biological Weapon
JAMA 285:1059-1070, Arnon,S.S.,et al, 2001
Treatment of Gustatory Sweating with Botulinum Toxin
Ann Neurol 42:973-975, Naumann,M.,et al, 1997
Blepharospasm:Report of a Workshop
Neurol 46:1213-1218, Hallett,M.&Daroff,R.B., 1996
Disabling Jaw Clonus in a Patient with Bulbar-Onset Amyotrophic Lateral Sclerosis Successfully Treated with Botulinum Toxin
Neurol 99:671, Santos, M.O.,et al, 2022
Treatment of Tics in People with Tourette Syndrome and Chronic Tic Disorders
Neurol 92:896-906, Pringsheim, T.,et al, 2019
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
Migraine
NEJM 377:553-561, Charles, A., 2017
Bilateral Hypertrophy of Masseteric and Temporalis Muscles, our Fifteen Patients and Review of Literature
Eur Rev Med Pharmacol Sci 20:7-11, Graziano, P.,et al, 2016
Evidence-Based Treatments for Adults with Migraine
Pain Reser Treat 2015:DOI:10.1155/2015/629382, Gooriah, R.,et al, 2015
Cerebral Palsy
Lancet 383:1240-1248, Colver, A.,et al, 2014
The Treatment of Dystonic Tremor: A Systematic Review
JNNP 85:759-769, Fasano, A.,et al, 2014
The Management of Spasticity in Adults
BMJ 349:g4737, Nair, K.P.S. & Marsden, J., 2014
Long-Term Improvement of Musicians Dystonia after Stereotactic Ventro-Oral Thalamotomy
Ann Neurol 74:648-654,627, Horisawa, S.,et al, 2013
Practice Parameter: Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy (an Evidence-Based Review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society
Neurol 74:336-343, Delgado,M.R.,et al, 2010
Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010
Update on Blepharospasm: Report from the BEBRF International Workshop
Neurol 71:1275-1282, Hallett,M.,et al, 2008
Clinical Update:Diagnosis and Treatment of Essential Tremor
Lancet 369:1152-1154, Benito-Leon,J&Louis,E.D., 2007
Botulinum Toxin A Treatment for Primary Hemifacial Spasm
Arch Neurol 59:418-420, Defazio,G.,et al, 2002
Blepharospasm
Neurol 59:1306-1312, Hallett,M., 2002
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
Physician Assistants in Neurology Practice
Neurol 52:1513, Taft,J.M.&Hooker,R.S., 1999
Long Term Results of Botulinum Toxin Type A (Dysport) in the Treatment of Hemifacial Spasm:A Report of 175 Cases
JNNP 64:751-757, Jitpimolmard,S.,et al, 1998
Tongue Protrusion Dystonia:Treatment with Botulinum Toxin
South Med J 90:522-525, Charles,P.D.,et al, 1997
Botulinum Toxin-A Improves the Rigidity of Progressive Supranuclear Palsy
Ann Neurol 35:237-239, Polo,K.B.&Jabbari,B., 1994
Botulinum Toxin in the Cerebral Palsies
BMJ 309:1526-1527, Neville,B., 1994
Botulinum Toxin, Useful in Adult Onset Focal Dystonias
BMJ 305:1169-1170, Lees,A.J., 1992
Therapeutic Uses Of Botulinum Toxin
NEJM 324:1186-1194, Jankovic,J.&Brin,M.F., 1991
Cervical Dystonia:Clinical Findings and Associated Movement Disorders
Neurol 41:1088-1091, Jankovic,J.,et al, 1991
Thyroid-Associated Eye Disease:Clinical Management
Lancet 338:29-32, Fells,P., 1991
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Infant Botulism:A Review of 12 Years'Experience at the Children; s Hosp of Phila
Pediatrics 87:159-165, Schreiner,M.S.,et al, 1991
Botulinum Toxin Treatment of Cranial-Cervical Dystonia, Spasmodic Dystonia, Focal Dystonias & Hemifacial Spasm
JNNP 53:633-639, Jankovic,J.,et al, 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Blepharospasm
Editorial, Lancet 2:10591988., , 1988
Blepharospasm:A Review of 264 Patients
JNNP 51:767-772, Grandas,F.,et al, 1988
Effect of Treatment with Botulinum Toxin on Neurogenic Blepharospasm
BMJ 290:1857-1859, Elston,J.S.,et al, 1985
Blepharospasm, Meige Syndrome, & Hemifacial Spasm:Treatment with Botulinum Toxin
Neurol 35:1499-1500, Mauriello,J.A., 1985
Trial of Botulinum Toxin for Isolated or Essential Head Tremor
NEJM 389:1753-1765, Marques,A.,et al, 2023
Placebo-Controlled, Randomized, Double-Blind Study of IncobotulinumtoxinA for Sialorrhea
Neurol 92:e1982-e1991, Jost, W.H.,et al, 2019
Efficacy of Botulinum Toxin A for Treating Cramps in Diabetic Neuropathy
Ann Neurol 84:682-690, Restivo, D.A.,et al, 2018
Pharmacotherapy for Diabetic Peripheral Neuropathy Pain and Quality of Life
Neurol 88:1958-1967, Waldfogel, J.M.,et al, 2017
Botulinum Toxin Type A for Neuropathic Pain in Patients with Spinal Cord Injury
Ann Neurol 79:569-578, Han, Z.A.,et al, 2016
Practice Guideline Update Summary: Botulinum Neurotoxin for the Treatment of Blepharospasm, Cervical Dystonia, Adult Spasticity, and Headache
Neurol 86:1818-1826, Simpson, D.M.,et al, 2016